Deutsche Bank
ISEE

Deutsche Bank’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Deutsche Bank’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,192,342
Closed -$126M – 3939
2023
Q2 		$126M Buy
3,192,342
+1,910,414
+149% +$67.4M 0.07% 279
2023
Q1 		$31.2M Sell
1,281,928
-1,148,521
-47% -$25.1M 0.02% 646
2022
Q4 		$52M Buy
2,430,449
+13,578
+0.6% +$290K 0.03% 496
2022
Q3 		$43.4M Sell
2,416,871
-4,451
-0.2% -$58.4K 0.03% 530
2022
Q2 		$23.3M Buy
2,421,322
+2,317,598
+2,234% +$29.1M 0.01% 745
2022
Q1 		$1.75M Buy
103,724
+32,482
+46% +$480K ﹤0.01% 1985
2021
Q4 		$1.19M Sell
71,242
-475,961
-87% -$7.8M ﹤0.01% 2329
2021
Q3 		$8.89M Buy
547,203
+98,541
+22% +$1.07M ﹤0.01% 1207
2021
Q2 		$2.83M Buy
448,662
+2,306
+0.5% +$14.9K ﹤0.01% 1916
2021
Q1 		$2.76M Sell
446,356
-201,742
-31% -$1.22M ﹤0.01% 1934
2020
Q4 		$4.48M Buy
648,098
+558,853
+626% +$3.58M ﹤0.01% 1423
2020
Q3 		$503K Buy
89,245
+68,482
+330% +$327K ﹤0.01% 2629
2020
Q2 		$106K Sell
20,763
-801,287
-97% -$3.34M ﹤0.01% 3404
2020
Q1 		$2.83M Buy
+822,050
New +$4.8M ﹤0.01% 1523
2019
Q4 		– Sell
-9,243
Closed -$10K – 5188
2019
Q3 		$10K Sell
9,243
-131,107
-93% -$153K ﹤0.01% 4513
2019
Q2 		$182K Sell
140,350
-78,876
-36% -$108K ﹤0.01% 3878
2019
Q1 		$309K Buy
219,226
+68,300
+45% +$95.5K ﹤0.01% 3742
2018
Q4 		$181K Sell
150,926
-40,461
-21% -$78.4K ﹤0.01% 3929
2018
Q3 		$452K Sell
191,387
-406,564
-68% -$1.01M ﹤0.01% 3836
2018
Q2 		$1.63M Sell
597,951
-188,525
-24% -$520K ﹤0.01% 3101
2018
Q1 		$2.15M Sell
786,476
-342,416
-30% -$993K ﹤0.01% 2813
2017
Q4 		$3.52M Sell
1,128,892
-95,567
-8% -$269K ﹤0.01% 2315
2017
Q3 		$3.45M Buy
1,224,459
+255,190
+26% +$689K ﹤0.01% 2156
2017
Q2 		$2.48M Buy
969,269
+16,000
+2% +$43.6K ﹤0.01% 2413
2017
Q1 		$3.49M Buy
953,269
+932,514
+4,493% +$3.94M ﹤0.01% 1900
2016
Q4 		$99K Sell
20,755
-91,147
-81% -$2.71M ﹤0.01% 4087
2016
Q3 		$5.16M Buy
111,902
+17,009
+18% +$959K ﹤0.01% 1701
2016
Q2 		$4.84M Buy
94,893
+34,630
+57% +$1.72M ﹤0.01% 1793
2016
Q1 		$2.54M Buy
60,263
+26,680
+79% +$1.36M ﹤0.01% 2208
2015
Q4 		$2.63M Buy
33,583
+7,306
+28% +$422K ﹤0.01% 2239
2015
Q3 		$1.06M Sell
26,277
-53,134
-67% -$2.81M ﹤0.01% 2902
2015
Q2 		$4.13M Sell
79,411
-27,968
-26% -$1.39M ﹤0.01% 1928
2015
Q1 		$5M Buy
107,379
+89,966
+517% +$4.67M ﹤0.01% 1788
2014
Q4 		$781K Sell
17,413
-12,244
-41% -$514K ﹤0.01% 3372
2014
Q3 		$1.15M Buy
29,657
+23,425
+376% +$919K ﹤0.01% 2921
2014
Q2 		$262K Buy
6,232
+1,801
+41% +$66.1K ﹤0.01% 3955
2014
Q1 		$157K Buy
4,431
+4,369
+7,047% +$147K ﹤0.01% 4018
2013
Q4 		$2K Buy
+62
New +$1.84K ﹤0.01% 5208

Deutsche Bank's ISEE Position: Q3 2023 in Review

Deutsche Bank sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 3,192,342 shares — an estimated $126M sold.

Deutsche Bank first reported a position in ISEE in Q4 2013 and held it in 38 quarters. The position peaked at $126M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Deutsche Bank reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Deutsche Bank sold 3,192,342 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $126M.
  • Deutsche Bank first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 38 quarters.
  • Deutsche Bank's IVERIC bio, Inc. Common Stock position peaked at $126M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.